Agomab Therapeutics NV (AGMB) reporting calendar
Agomab Therapeutics NV files periodic reports with the SEC as AGMB on Nasdaq. Atlas tracks 1 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 23 Apr 2026
- Reports on record
- 1
Open AGMB market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 23 Apr 2026 | 113 days | 0001104659-26-047872 |
Source: SEC EDGAR company submissions for CIK 0002020932. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.